Covered recipient · General Payments record
SAMANTHA IJEOMA DE GANNES
Allopathic & Osteopathic Physicians Psychiatry & Neurology Epilepsy
General Payments · PY2021–2024
$1,008.49
- Reported across 38 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $259.04 | 20 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $181.58 | 17 |
| Sandoz Inc. | $29.70 | 1 |
| ARGENX US, INC. | $29.36 | 1 |
| Acorda Therapeutics, Inc | $18.40 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (20)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $8.75 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103613108 | CMS |
| ABBVIE INC. | $2.16 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103613110 | CMS |
| ABBVIE INC. | $11.52 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103613112 | CMS |
| ABBVIE INC. | $2.72 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103613114 | CMS |
| ABBVIE INC. | $11.52 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103613116 | CMS |
| ABBVIE INC. | $16.93 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103613118 | CMS |
| ABBVIE INC. | $11.81 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103613120 | CMS |
| ABBVIE INC. | $16.14 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103613122 | CMS |
| ABBVIE INC. | $28.36 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103613124 | CMS |
| ABBVIE INC. | $11.37 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103613126 | CMS |
| ABBVIE INC. | $11.10 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103613128 | CMS |
| ABBVIE INC. | $2.18 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103613130 | CMS |
| ABBVIE INC. | $11.65 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103613132 | CMS |
| ABBVIE INC. | $10.52 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103613134 | CMS |
| ABBVIE INC. | $11.94 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103613136 | CMS |
| ABBVIE INC. | $1.64 | 10/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103613138 | CMS |
| ABBVIE INC. | $11.27 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103613140 | CMS |
| Acorda Therapeutics, Inc | $18.40 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142349906 | CMS |
| ARGENX US, INC. | $29.36 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142127253 | CMS |
| Sandoz Inc. | $29.70 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089374985 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.